$BDX
Análise IAGerado em May 11, 2026
AI Score
Hold$BDX
Becton Dickinson and Co.
$BDXNYSEHealthcareLarge-Cap
Becton Dickinson develops and sells medical technology products for medication management, diagnostics, and biosciences.
Market Cap
$68.0B
Revenue (TTM)
$20.2B
+4.0%
Net Income (TTM)
$1.8B
+6.0%
EPS (TTM)
$2.50
P/E Ratio
58.0
Dividend Yield
1.3%
52-Week Range
$215-$260
Beta
0.62
Dimension Scores
Fundamental
70Technical
62Sentiment
66Risk / Reward
72Momentum
58Financial Health
Profitability
75moderate
Growth
61moderate
Liquidity
80strong
Solvency
72strong
Efficiency
68strong
Valuation, technical analysis, investment thesis, risk assessment and more for $BDX
Free · No credit card required
Aviso: Análise gerada por IA apenas para fins educacionais. Não constitui aconselhamento financeiro. Sempre consulte um consultor financeiro qualificado.